HomeMedical SpecialtiesCardiologyThe golden future of cardiac tissue repair

The golden future of cardiac tissue repair

Published on

Researchers at the University of Ottawa Heart Institute (UOHI) have discovered gold nanoparticles and synthesized peptides restore function, contractility, and electrical conductivity to damaged heart tissue – a scientific feat which may one day be applied to save human lives.

The breakthrough research made the cover of the March issue of ACS Nano, a monthly, peer-reviewed, scientific journal of the American Chemical Society.

Dr. Marcelo Muñoz, a chemist in the Bio-Engineering and Therapeutic Solutions (BEaTS) Laboratory at the UOHI, and the primary author of the study along with fellow researcher, scientist and PhD candidate Cagla Eren Cimenci, said heart attack survivors are increasing thanks to leaps in scientific innovation, technology, and patient care. On the other hand, many heart attack survivors go on to develop an often-fatal condition called heart failure, which results from injuries sustained during the attack.

When a heart attack (myocardial infarction) occurs, one or more of the coronary arteries shut down, cutting off blood supply, nutrients, and oxygen to cells (cardiomyocytes) on the heart. Without rapid intervention, the affected tissue is lost and cannot be recovered. A scar forms on the heart and, over time, the muscle weakens, until ultimately, it fails. Patients with heart failure are no longer capable of pumping enough blood to meet their bodies’ demands.

Paradoxically, as deaths from heart attacks drop off, deaths from heart failure are on the rise. In Canada, as many as 750,000 people live with heart failure and 100,000 are diagnosed with the condition each year. Such staggering figures present scientists like Dr. Muñoz with important questions: Is a therapeutic solution capable of recovering damaged heart tissue even possible, and if so, can scientists use one to prevent a heart attack patient from becoming a patient with heart failure?

To date, no such therapy exists. However, early tests in mice are proving demonstratively positive.

Gold nanoparticles – that is, tiny flecks of gold so small they are invisible to the naked eye – have been of keen interest to scientists for years. Their properties make them ideal for use in a variety of applications, including in electronics, nanotechnology and biomedicine.

Muñoz and his colleagues encapsulated and stabilized these tiny golden nanoparticles with nanoengineered peptides (strings of amino acids). The peptides were fortified with spider-like branches that stem outward from their core. Then, by using a specially designed micro-nozzle (imagine a can of spray paint with a tip so fine it could deliver the application within micrometres), the nanoparticle and peptide solution was sprayed onto a localized area of the heart.

“When applied to mouse hearts, one week after infarction, the spray-on treatment resulted in an increase in cardiac function (2.4-fold), muscle contractility, and myocardial electrical conductivity,” writes Dr. Muñoz and his colleagues. “Our cumulative data suggest that the therapeutic action of our spray-on nanotherapeutic is highly effective, and in practice, its application is simpler than other regenerative approaches for treating an infarcted heart.”

Researchers have studied stem cell injections, cardiac patches, exosome delivery, and drugs, but these approaches to myocardial tissue regeneration have not yet translated into the clinic. Stem cell therapies offer great promise for new medical treatments; however, the process is costly and can take months. The gold nanotherapeutic system developed at the UOHI can be stored in the fridge, is ready to use when required, remains stable over time, and is a fraction of the cost.

 

Latest articles

New emergency protocol brings together multidisciplinary care teams

A cyclist is struck by a car and in critical condition. In the Emergency Department...

London Health Sciences Centre reduces cancer surgery wait times by 50 per cent

Through several focused strategies and a dedicated team effort, London Health Sciences Centre (LHSC)...

Conquering a chronic lung infection

Lung problems plagued David Shoots since his youth. It would take buying a dream...

Transitioning older adults back home after hospital

Headwaters Health Care Centre (Headwaters) is pleased to announce its partnership with Bayshore HealthCare...

More like this

London Health Sciences Centre reduces cancer surgery wait times by 50 per cent

Through several focused strategies and a dedicated team effort, London Health Sciences Centre (LHSC)...

Southlake pioneering advancements in cardiac care

Southlake Regional Health Centre is setting new benchmarks that will bring leading edge cardiac...

Wildfire smoke and health

With wildfires becoming more frequent and extensive in Canada, it’s important for people to...

Many health-care providers are ill-equipped to recognize pain in abused children

McGill study finds only 13 per cent of those surveyed received training on child...

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD

It’s estimated that 70 per cent of people with asthma or COPD go undiagnosed....

Timely diagnosis and right medication lead to improved quality of life for heart failure patients

Marilyn Jackson recalls waking up, breathless, with a terrible cramp in her leg. “I’m...